Privia Health Group (NASDAQ:PRVA) CEO Parth Mehrotra Sells 26,763 Shares

Privia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra sold 26,763 shares of the firm’s stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $21.90, for a total transaction of $586,109.70. Following the transaction, the chief executive officer directly owned 609,181 shares of the company’s stock, valued at $13,341,063.90. The trade was a 4.21% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Parth Mehrotra also recently made the following trade(s):

• On Friday, March 13th, Parth Mehrotra sold 27,229 shares of Privia Health Group stock. The stock was sold at an average price of $21.52, for a total transaction of $585,968.08.
• On Tuesday, March 10th, Parth Mehrotra sold 21,097 shares of Privia Health Group stock. The shares were sold at an average price of $22.71, for a total value of $479,112.87.
• On Monday, March 9th, Parth Mehrotra sold 41,999 shares of Privia Health Group stock. The stock was sold at an average price of $22.86, for a total value of $960,097.14.
• On Friday, March 6th, Parth Mehrotra sold 21,440 shares of Privia Health Group stock. The stock was sold at an average price of $23.15, for a total value of $496,336.00.

Privia Health Group Trading Up 1.3%

Shares of PRVA opened at $21.96 on Tuesday. The stock’s 50-day moving average price is $22.85 and its two-hundred day moving average price is $23.62. Privia Health Group, Inc. has a 12 month low of $18.77 and a 12 month high of $26.51. The company has a market capitalization of $2.72 billion, a PE ratio of 129.18, a PEG ratio of 1.37 and a beta of 0.82.

Privia Health Group (NASDAQ:PRVA) last issued its quarterly earnings results on Thursday, February 26th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.21. Privia Health Group had a return on equity of 3.06% and a net margin of 1.08%.The company had revenue of $541.17 million during the quarter, compared to analysts’ expectations of $516.61 million. During the same quarter in the prior year, the firm posted $0.21 earnings per share. The business’s quarterly revenue was up 17.4% on a year-over-year basis. Equities research analysts predict that Privia Health Group, Inc. will post 0.14 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

PRVA has been the subject of a number of recent analyst reports. Canaccord Genuity Group increased their target price on shares of Privia Health Group from $34.00 to $35.00 and gave the company a “buy” rating in a research report on Friday, February 27th. Royal Bank Of Canada started coverage on shares of Privia Health Group in a research note on Friday, January 9th. They issued an “outperform” rating and a $31.00 price objective on the stock. Stephens reissued an “overweight” rating and set a $32.00 target price on shares of Privia Health Group in a research note on Thursday, December 4th. Wolfe Research set a $31.00 target price on shares of Privia Health Group in a report on Tuesday, January 6th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $32.00 price target on shares of Privia Health Group in a research report on Thursday, February 26th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, Privia Health Group has an average rating of “Moderate Buy” and an average target price of $31.00.

Institutional Trading of Privia Health Group

Several hedge funds have recently bought and sold shares of PRVA. Royal Bank of Canada increased its position in shares of Privia Health Group by 63.5% during the first quarter. Royal Bank of Canada now owns 245,633 shares of the company’s stock worth $5,514,000 after acquiring an additional 95,371 shares in the last quarter. AQR Capital Management LLC lifted its position in Privia Health Group by 24.7% in the 1st quarter. AQR Capital Management LLC now owns 40,781 shares of the company’s stock valued at $916,000 after acquiring an additional 8,068 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Privia Health Group by 3.2% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 118,764 shares of the company’s stock valued at $2,666,000 after purchasing an additional 3,714 shares during the last quarter. Intech Investment Management LLC boosted its stake in Privia Health Group by 55.1% during the 1st quarter. Intech Investment Management LLC now owns 56,553 shares of the company’s stock valued at $1,270,000 after purchasing an additional 20,082 shares during the last quarter. Finally, Acadian Asset Management LLC bought a new stake in Privia Health Group during the 1st quarter worth approximately $154,000. Institutional investors and hedge funds own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.